Polygon Management Ltd.
- SEC CIK
- 0001515070
- Latest filing
- Aug 12, 2026
TARS holding history
Tarsus Pharmaceuticals, Inc. in every 13F filed by Polygon Management Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TARS overviewAll 13F holders of TARSFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −125,000−100.0% | Sold out | Holders |
| Q3 2025 | 125,000 | $7.43M | 1.1% | −125,000−50.0% | Reduced | Holders |
| Q2 2025 | 250,000 | $10.1M | 1.8% | +71,530+40.1% | Added | Holders |
| Q1 2025 | 178,470 | $9.17M | 2.9% | −21,530−10.8% | Reduced | Holders |
| Q4 2024 | 200,000 | $11.1M | 3.6% | −414,117−67.4% | Reduced | Holders |
| Q3 2024 | 614,117 | $20.2M | 6.4% | +114,117+22.8% | Added | Holders |
| Q2 2024 | 500,000 | $13.6M | 4.2% | +50,000+11.1% | Added | Holders |
| Q1 2024 | 450,000 | $16.4M | 4.5% | −350,000−43.8% | Reduced | Holders |
| Q4 2023 | 800,000 | $16.2M | 4.1% | +185,000+30.1% | Added | Holders |
| Q3 2023 | 615,000 | $10.9M | 2.0% | +450,000+272.7% | Added | Holders |
| Q2 2023 | 165,000 | $2.98M | 0.4% | +165,000 | New | Holders |